Canopy Growth Corporation

NASDAQ:CGC

Drug Manufacturers - Specialty & Generic

Healthcare
$0.50 +1.07%

+$0.01 today

Market cap
$212.31M
Beta
0.78
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $0.84High $2.38

Volume 3.44M

Average 9.97M

CGC Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Canopy Growth CorporationNASDAQ: CGC

Weighted Avg Shares (Diluted) · Q4 FY2025 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q4 FY2025 weighted avg shares (diluted) of 384.99M shares rose 257.9% year over year, ahead of the +210.7% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 11.4% from the prior quarter. Over 3 fiscal years it compounded at +300.6% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +257.9% holds above the trailing-twelve-month pace of +210.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
384.99M+11.4% QoQ
Last fiscal yearMar 2026
2.98B+2671.1% YoY
LTMMar 2026
298.22M+210.7% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+257.9%——
1 year+2671.1%——
3-year CAGR+300.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
2.98B CAD
Year-over-year change
+2671.1%
4-year CAGR
+195.4%

Weighted Avg Shares (Diluted) vs competitors

How CGC compares with its peers on the latest reported figures

  • CGC's LTM Mar 2026 weighted avg shares (diluted) of 298.22M shares is the highest of the 10 companies compared; the peer median is 56.58M shares.
  • Its year-over-year change of +210.7% is the highest of 9, against a peer median of +9.4%.
  • Over three fiscal years its annual growth of +300.6% compares with a peer median of +11.4%.
CGC Competitors Peer median
Weighted Avg Shares (Diluted) for CGC and competitors
Company Period LTM YoY 3-year CAGR
CGCCanopy Growth CorporationLTM Mar 2026298.22M +210.7%+300.6%
IRWDIronwood Pharmaceuticals, Inc.LTM Mar 2026170.99M +6.8%-1.6%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026124.17M +37.8%+23.4%
DHDefinitive Healthcare Corp.LTM Mar 2026104.66M -9.4%+1.8%
CABACabaletta Bio, Inc.LTM Mar 202694.61M +90.6%+51.6%
ACBAurora Cannabis Inc.LTM Mar 202656.58M +3.1%+20.7%
TKNOAlpha Teknova, Inc.LTM Mar 202653.53M +11.4%+24.0%
BIOABioAge Labs, Inc.LTM Mar 202637.57M +7.3%+1.7%
LFCRLifecore Biomedical, Inc.LTM Mar 202637.34M —+5.7%
LYELLyell Immunopharma, Inc.LTM Mar 202618.01M +34.2%+11.4%
Peer median (excluding CGC) 56.58M+9.4%+11.4%

Competitors are the stored peer set for CGC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue475.7M333.25M297.15M269M483.67M
Cost of Revenue663.11M396.78M216.26M189.48M386.51M
Gross Profit(187.41M)(63.53M)80.88M79.51M97.16M
Gross Margin-39.4%-19.1%27.2%29.6%20.1%
Research & Development32.26M21.72M4.61M1.91M0
Selling, General & Admin361.1M297.98M180.59M121.71M223.11M
Operating Expenses831.39M2.57B309.6M196.65M322.6M
Depreciation & Amortization110.94M80.03M53.18M43.12M50.86M
EBITDA(52.98M)(2.88B)(312.83M)(479.31M)50.86M
EBITDA Margin-11.1%-864.2%-105.3%-178.2%10.5%
Operating Income(1.02B)(2.63B)(228.71M)(117.14M)(161.66M)
Operating Margin-214.2%-789.3%-77.0%-43.5%-33.4%
Interest Income6.6M24.28M16.24M8.82M10M
Interest Expense103.94M126.16M105.35M74.57M38.19M
Other Income / Expenses750.94M(455.64M)(242.64M)(479.85M)(101.23M)
Income Before Tax(267.86M)(3.09B)(471.36M)(597M)(262.89M)
Pre-Tax Margin-56.3%-926.1%-158.6%-221.9%-54.4%
Income Tax Expense(8.95M)(5.73M)12.33M7.14M23K
Net Income(310.04M)(3.28B)(657.27M)(598.12M)(366.64M)
Net Margin-65.2%-983.7%-221.2%-222.4%-75.8%
EPS (Basic)(7.70)(70.70)(6.47)(5.53)(0.88)
EPS (Diluted)(7.70)(70.70)(8.79)(5.53)(0.88)
Weighted Avg Shares39.13M46.37M101.63M107.55M2.98B
Weighted Avg Shares (Diluted)39.13M46.37M74.79M107.55M2.98B

Canopy Growth Corporation

NASDAQ:CGC

Intrinsic Alpha fair value

Locked

Current Price

$0.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.